0001209191-23-055526.txt : 20231116 0001209191-23-055526.hdr.sgml : 20231116 20231116163000 ACCESSION NUMBER: 0001209191-23-055526 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20231115 FILED AS OF DATE: 20231116 DATE AS OF CHANGE: 20231116 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: HIGH SUSANNA GATTI CENTRAL INDEX KEY: 0001691005 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39509 FILM NUMBER: 231414993 MAIL ADDRESS: STREET 1: 75 LORIMER ROAD CITY: BELMONT STATE: MA ZIP: 02141 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Dyne Therapeutics, Inc. CENTRAL INDEX KEY: 0001818794 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 364883909 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1560 TRAPELO ROAD CITY: WALTHAM STATE: MA ZIP: 02451 BUSINESS PHONE: (781) 786-8230 MAIL ADDRESS: STREET 1: 1560 TRAPELO ROAD CITY: WALTHAM STATE: MA ZIP: 02451 4 1 doc4.xml FORM 4 SUBMISSION X0508 4 2023-11-15 0 0001818794 Dyne Therapeutics, Inc. DYN 0001691005 HIGH SUSANNA GATTI C/O DYNE THERAPEUTICS, INC. 1560 TRAPELO ROAD WALTHAM MA 02451 0 1 0 0 Chief Operating Officer 0 Common Stock 2023-11-15 4 A 0 94893 0.00 A 189498 D Stock Option (right to buy) 10.88 2023-11-15 4 A 0 36952 0.00 A 2033-11-14 Common Stock 36952 36952 D Consists of shares of Common Stock issuable under 94,893 restricted stock units ("RSUs"). Each RSU represents the right to receive one share of Common Stock upon vesting. These RSUs are scheduled to vest in equal quarterly installments over four years with the first installment vesting on February 15, 2024. Includes 162,299 unvested RSUs. This option was granted on November 15, 2023. The shares underlying the option are scheduled to vest over four years in equal monthly installments through November 15, 2027. /s/ Richard Scalzo, Attorney-in-Fact 2023-11-16